Genomics and epidemiology of the P.1 SARS-CoV-2 lineage in Manaus, Brazil

Cited by (1,006)

Items 201–300 of 1,006

1. Therapeutic effect of CT-P59 against SARS-CoV-2 South African variant
   Dong-Kyun Ryu, Rina Song, Minsoo Kim, Young‐Il Kim, Cheol-Min Kim, Jong‐In Kim, Ki-Sung Kwon, Aloys S.L. Tijsma, Patricia M. Nuijten, Carel A. van Baalen et al. · 2021 · Biochemical and Biophysical Research Communications
2. Physicochemical effect of the N501Y, E484K/Q, K417N/T, L452R and T478K mutations on the SARS-CoV-2 spike protein RBD and its influence on agent fitness and on attributes developed by emerging variants of concern
   Robério Amorim de Almeida Pondé · 2022 · Virology
3. Current Advances in Paper-Based Biosensor Technologies for Rapid COVID-19 Diagnosis
   Soohyun Kim, Jong‐Hwan Lee · 2022 · BioChip Journal
4. Understanding the Secret of SARS-CoV-2 Variants of Concern/Interest and Immune Escape
   Fuxing Lou, Maochen Li, Zehan Pang, Lin Jiang, Lin Guan, Lili Tian, Jiaming Hu, Junfen Fan, Huahao Fan · 2021 · Frontiers in Immunology
5. Emerging SARS-CoV-2 Variants Can Potentially Break Set Epidemiological Barriers in COVID-19
   Ashutosh Kumar, Rakesh Parashar, Sujeet Kumar, Muneeb A. Faiq, Chiman Kumari, Maheswari Kulandhasamy, Ravi Kant Narayan, Rakesh K. Jha, Himanshu Narayan Singh, Pranav Prasoon et al. · 2021 · Journal of Medical Virology
6. Genomic analysis reveals a rapid spread and predominance of lambda (C.37) SARS‐COV‐2 lineage in Peru despite circulation of variants of concern
   Carlos Padilla, Víctor Jimenez‐Vasquez, Verónica Hurtado, Orson Mestanza, Iris S. Molina, Luis Barcena, Sandra Morales Ruiz, Steve V. Acedo-Lazo, Wendy C. Lizárraga, Henri Bailón et al. · 2021 · Journal of Medical Virology
7. The effect of COVID-19 vaccination in Italy and perspectives for living with the virus
   Valentina Marziano, Giorgio Guzzetta, Alessia Mammone, Flavia Riccardo, Piero Poletti, Filippo Trentini, Mattia Manica, Andrea Siddu, Antonino Bella, Paola Stefanelli et al. · 2021 · Nature Communications
8. The way of SARS-CoV-2 vaccine development: success and challenges
   Yetian Dong, Tong Dai, Bin Wang, Lei Zhang, Linghui Zeng, Jun Huang, Haiyan Yan, Long Zhang, Fangfang Zhou · 2021 · Signal Transduction and Targeted Therapy
9. The prevalence of adaptive immunity to COVID-19 and reinfection after recovery – a comprehensive systematic review and meta-analysis
   Tawanda Chivese, Joshua T. Matizanadzo, Omran A. H. Musa, George Hindy, Luis Furuya‐Kanamori, Nazmul Islam, Rafal Al-Shebly, Rana Shalaby, Mohammad Habibullah, Talal A. Al-Marwani et al. · 2022 · Pathogens and Global Health
10. The Impact of Angiotensin-Converting Enzyme 2 (ACE2) Expression Levels in Patients with Comorbidities on COVID-19 Severity: A Comprehensive Review
    Rui Rodrigues, Sofia Costa‐de‐Oliveira · 2021 · Microorganisms
11. Spread of Gamma (P.1) Sub-Lineages Carrying Spike Mutations Close to the Furin Cleavage Site and Deletions in the N-Terminal Domain Drives Ongoing Transmission of SARS-CoV-2 in Amazonas, Brazil
    Felipe Gomes Naveca, Valdinete Alves do Nascimento, Victor Costa de Souza, André de Lima Guerra Corado, Fernanda Nascimento, George Silva, Matilde Mejía, Maria Júlia Brandão, Ágatha Costa, Débora Duarte et al. · 2022 · Microbiology Spectrum
12. Inter-domain communication in SARS-CoV-2 spike proteins controls protease-triggered cell entry
    Enya Qing, Pengfei Li, Laura M. Cooper, Sebastian R. Schulz, Hans‐Martin Jäck, Lijun Rong, Stanley M. Perlman, Tom Gallagher · 2022 · Cell Reports
13. The Importance of RNA-Based Vaccines in the Fight against COVID-19: An Overview
    Bruna Aparecida Souza Machado, Katharine Valéria Saraiva Hodel, Larissa Moraes dos Santos Fonseca, Luis Alberto Breda Mascarenhas, Leone Peter Correia da Silva Andrade, Vinícius Pinto Costa Rocha, Milena Botelho Pereira Soares, Peter Berglund, Malcolm S. Duthie, Steven G. Reed et al. · 2021 · Vaccines
14. Multiple Routes of Antibody-Dependent Enhancement of SARS-CoV-2 Infection
    Kosuke Okuya, Takanari Hattori, Takeshi Saito, Yoshihiro Takadate, Michihito Sasaki, Wakako Furuyama, Andrea Marzi, Yoichi Ohiro, Satoshi Konno, Takeshi Hattori et al. · 2022 · Microbiology Spectrum
15. SARS-CoV-2 variant Delta rapidly displaced variant Alpha in the United States and led to higher viral loads
    Bolze, Alexandre, Cirulli, Elizabeth T, Luo, Shishi, White, Simon, Wyman, Dana, Dei Rossi, Andrew, Machado, Henrique, Cassens, Tyler, Jacobs, Sharoni, Schiabor Barrett, Kelly M. et al. · 2021
16. D614G mutation and SARS-CoV-2: impact on S-protein structure, function, infectivity, and immunity
    Manojit Bhattacharya, Srijan Chatterjee, Ashish Ranjan Sharma, Govindasamy Agoramoorthy, Chiranjib Chakraborty · 2021 · Applied Microbiology and Biotechnology
17. Lung fibrosis: Post-COVID-19 complications and evidences
    Rishabh Hirawat, Namrata Jain, Mohd Aslam Saifi, Mahesh Rachamalla, Chandraiah Godugu · 2022 · International Immunopharmacology
18. SARS-CoV-2: phenotype, genotype, and characterization of different variants
    Mohammadreza Saberiyan, Elham Karimi, Zahra Khademi, Parvaneh Movahhed, Amir Safi, Ameneh Mehri Ghahfarrokhi · 2022 · Cellular & Molecular Biology Letters
19. The “Delta Plus” COVID-19 variant has evolved to become the next potential variant of concern: mutation history and measures of prevention
    Fahad Imtiaz Rahman, Sadia Afruz Ether, Md. Rabiul Islam · 2021 · Journal of Basic and Clinical Physiology and Pharmacology
20. Lives saved and hospitalizations averted by COVID-19 vaccination in New York City: a modeling study
    Affan Shoukat, THOMAS NOGUEIRA VILCHES, Seyed M. Moghadas, Pratha Sah, Eric C. Schneider, Jaimie Shaff, Jane R. Zucker, Celia Quinn, Dave A. Chokshi, Alison P. Galvani · 2021 · The Lancet Regional Health - Americas
21. Variations within the Glycan Shield of SARS-CoV-2 Impact Viral Spike Dynamics
    Maddy L. Newby, Carl A. Fogarty, Joel D. Allen, John Butler, Elisa Fadda, Max Crispin · 2022 · Journal of Molecular Biology
22. Epitope profiling reveals binding signatures of SARS-CoV-2 immune response in natural infection and cross-reactivity with endemic human CoVs
    Caitlin I. Stoddard, Jared Galloway, Helen Y. Chu, Mackenzie M. Shipley, Kevin Sung, Hannah L. Itell, Caitlin R. Wolf, Jennifer K. Logue, Ariana Magedson, Meghan E. Garrett et al. · 2021 · Cell Reports
23. Human Organoids and Organs‐on‐Chips for Addressing COVID‐19 Challenges
    Yaqing Wang, Peng Wang, Jianhua Qin · 2022 · Advanced Science
24. Genomic epidemiology of SARS-CoV-2 under an elimination strategy in Hong Kong
    Haogao Gu, Ruopeng Xie, Dillon Charles Adam, Joseph L.-H. Tsui, Daniel K. W. Chu, Lydia D.J. Chang, Sammi S.Y. Cheuk, Shreya Gurung, Pavithra Krishnan, Daisy Y.M. Ng et al. · 2022 · Nature Communications
25. COVID-19, the first pandemic in the post-genomic era
    Lucy van Dorp, Charlotte J. Houldcroft, Damien Richard, François Balloux · 2021 · Current Opinion in Virology
26. Interactions of the Receptor Binding Domain of SARS-CoV-2 Variants with hACE2: Insights from Molecular Docking Analysis and Molecular Dynamic Simulation
    İsmail Çeli̇k, Rohitash Yadav, Zekeriya Düzgün, Sarah M. Albogami, Ahmed M. El‐Shehawi, Fatimawali Fatimawali, Rinaldi Idroes, Trina Ekawati Tallei, Talha Bin Emran · 2021 · Biology
27. In silico study of some selective phytochemicals against a hypothetical SARS-CoV-2 spike RBD using molecular docking tools
    Anish Nag, Subhabrata Paul, Ritesh Banerjee, Rita Kundu · 2021 · Computers in Biology and Medicine
28. Fitness, growth and transmissibility of SARS-CoV-2 genetic variants
    Erik Volz · 2023 · Nature Reviews Genetics
29. SARS‐CoV‐2 virulence evolution: Avirulence theory, immunity and trade‐offs
    Samuel Alizon, Mircea T. Sofonea · 2021 · Journal of Evolutionary Biology
30. Emergence of an early SARS-CoV-2 epidemic in the United States
    Mark Zeller, Karthik Gangavarapu, Catelyn Anderson, Allison R. Smither, John A. Vanchiere, Rebecca Rose, Daniel J. Snyder, Gytis Dudas, Alexander Watts, Nathaniel L. Matteson et al. · 2021 · Cell
31. Genome-wide CRISPR screens identify GATA6 as a proviral host factor for SARS-CoV-2 via modulation of ACE2
    Ma’ayan Israeli, Yaara Finkel, Yfat Yahalom-Ronen, Nir Paran, Theodor Chitlaru, Ofir Israeli, Inbar Cohen-Gihon, Moshe Aftalion, Reut Falach, Shahar Rotem et al. · 2022 · Nature Communications
32. Evolutionary implications of SARS-CoV-2 vaccination for the future design of vaccination strategies
    Igor M. Rouzine, Ganna Rozhnova · 2023 · Communications Medicine
33. Safety and Immunogenicity of a Newcastle Disease Virus Vector-Based SARS-CoV-2 Vaccine Candidate, AVX/COVID-12-HEXAPRO (Patria), in Pigs
    Jesús Horacio Lara Puente, Juan Manuel Carreño, Weina Sun, Alejandro Suárez-Martínez, Luis Alfonso Ramírez-Martínez, Francisco Quezada-Monroy, Georgina Paz-De la Rosa, Rosalía Vigueras-Moreno, Gagandeep Singh, Oscar Rojas-Martínez et al. · 2021 · mBio
34. Multiplex Biosensing for Simultaneous Detection of Mutations in SARS-CoV-2
    Hui Xi, Hanlin Jiang, Mario Juhas, Yang Zhang · 2021 · ACS Omega
35. Evolution of resistance to COVID-19 vaccination with dynamic social distancing
    Gabriela Lobinska, Ady Pauzner, Arne Traulsen, Yitzhak Pilpel, Martin A. Nowak · 2022 · Nature Human Behaviour
36. ‘We are being ignored’: Brazil’s researchers blame anti-science government for devastating COVID surge
    Luke Taylor · 2021 · Nature
37. Covid-19: How many variants are there, and what do we know about them?: Video 1
    Elisabeth Mahase · 2021 · BMJ
38. Predominance of antibody-resistant SARS-CoV-2 variants in vaccine breakthrough cases from the San Francisco Bay Area, California
    Venice Servellita, Mary Kate Morris, Alicia Sotomayor-González, Amelia S. Gliwa, Erika Torres, Noah Brazer, Alicia Yiran Zhou, Katherine Hernandez, Madeline Sankaran, Baolin Wang et al. · 2022 · Nature Microbiology
39. Assessment of Neutralizing Antibody Response Against SARS-CoV-2 Variants After 2 to 3 Doses of the BNT162b2 mRNA COVID-19 Vaccine
    Koichi Furukawa, Lidya Handayani Tjan, Yukiya Kurahashi, Silvia Sutandhio, Mitsuhiro Nishimura, Jun Arii, Yasuko Mori · 2022 · JAMA Network Open
40. Molecular insights into the adaptive evolution of SARS-CoV-2 spike protein
    Zhuocheng Yao, Lin Zhang, Yuange Duan, Xiaolu Tang, Jian Lü · 2024 · Journal of Infection
41. In vitro Characterization of Fitness and Convalescent Antibody Neutralization of SARS-CoV-2 Cluster 5 Variant Emerging in Mink at Danish Farms
    Ria Lassaunière, Jannik Fonager, Morten Rasmussen, Anders Frische, Charlotta Polacek, Thomas Bruun Rasmussen, Louise Lohse, Graham J. Belsham, Alexander P. Underwood, Anni Assing Winckelmann et al. · 2021 · Frontiers in Microbiology
42. Structure and Mutations of SARS-CoV-2 Spike Protein: A Focused Overview
    Rukmankesh Mehra, Kasper P. Kepp · 2021 · ACS Infectious Diseases
43. A monoclonal antibody that neutralizes SARS-CoV-2 variants, SARS-CoV, and other sarbecoviruses
    Pengfei Wang, Ryan G. Casner, Manoj S. Nair, Jian Yu, Yicheng Guo, Maple Wang, Jasper Fuk‐Woo Chan, Gabriele Cerutti, Sho Iketani, Lihong Liu et al. · 2021 · Emerging Microbes & Infections
44. The Development of SARS-CoV-2 Variants: The Gene Makes the Disease
    Raquel Pérez-Gómez · 2021 · Journal of Developmental Biology
45. Clinical Characteristics, Transmissibility, Pathogenicity, Susceptible Populations, and Re-infectivity of Prominent COVID-19 Variants
    Zhen Lu Yang, Shuo Zhang, Yuping Tang, Sai Zhang, Ding-Qiao Xu, Shi‐Jun Yue, Qiling Liu · 2022 · Aging and Disease
46. Biological Properties of SARS-CoV-2 Variants: Epidemiological Impact and Clinical Consequences
    Reem Hoteit, Hadi Mohamad Yassine · 2022 · Vaccines
47. Tetravalent SARS-CoV-2 Neutralizing Antibodies Show Enhanced Potency and Resistance to Escape Mutations
    Shane Miersch, Zhijie Li, Reza Saberianfar, Mart Ustav, James Brett Case, Levi L. Blazer, Chao Chen, Wei Ye, Alevtina Pavlenco, Maryna Gorelik et al. · 2021 · Journal of Molecular Biology
48. Multiple expansions of globally uncommon SARS-CoV-2 lineages in Nigeria
    Egon Anderson Ozer, Lacy M. Simons, Moses Olubusuyi Adewumi, Adeola Fowotade, Ewean Chukwuma Omoruyi, Johnson Adekunle Adeniji, Oluseyi Adebowale Olayinka, Taylor J. Dean, Janet P. Zayas, Pavan P. Bhimalli et al. · 2022 · Nature Communications
49. Emergence of SARS-CoV-2 New Variants and Their Clinical Significance
    H. Singh, N. Dahiya, M. Yadav, Neelam Sehrawat · 2022 · The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale
50. COVID-19 ICU demand forecasting: A two-stage Prophet-LSTM approach
    DALTON BORGES, Mariá C. V. Nascimento · 2022 · Applied Soft Computing
51. Hybrid Immunity to SARS-CoV-2 from Infection and Vaccination—Evidence Synthesis and Implications for New COVID-19 Vaccines
    Júlia Spinardi, Amit K. Srivastava · 2023 · Biomedicines
52. Atazanavir Is a Competitive Inhibitor of SARS-CoV-2 Mpro, Impairing Variants Replication In Vitro and In Vivo
    Otávio Augusto Chaves, Carolina Q. Sacramento, André Costa Ferreira, Mayara Mattos, Natalia Fintelman Rodrigues, Jairo Ramos Temerozo, Douglas Pereira Pinto, Gabriel P. E. Silveira, Laís Bastos da Fonseca, Heliana Martins Pereira et al. · 2021 · Pharmaceuticals
53. International consensus on lung function testing during the COVID-19 pandemic and beyond
    Aisling McGowan, Pierantonio Laveneziana, Sam Bayat, Nicole Beydon, Piotr W. Boros, Felip Burgos, Matjaž Fležar, Monika Franczuk, Maria-Alejandra Galarza-Jimenez, Adrian Hugh Kendrick et al. · 2021 · ERJ Open Research
54. Pseudoscience and fraudulent products for COVID-19 management
    Vivek P. Chavda, Shreya S. Sonak, Nafesa K. Munshi, Pooja N. Dhamade · 2022 · Environmental Science and Pollution Research
55. A comparative overview of SARS‑CoV‑2 and its variants of concern
    Aqeel Ahmad, Mohammed Ali Mullah Fawaz, Arafeen Aisha · 2022 · Infezioni in Medicina
56. Contact tracing efficiency, transmission heterogeneity, and accelerating COVID-19 epidemics
    Billy J. Gardner, Auston Marm Kilpatrick · 2021 · PLoS Computational Biology
57. A Potential SARS-CoV-2 Variant of Interest (VOI) Harboring Mutation E484K in the Spike Protein Was Identified within Lineage B.1.1.33 Circulating in Brazil
    Paola Cristina Resende, Tiago Gräf, Anna Carolina Dias Paixão, Luciana Appolinario, Renata Serrano Lopes, Ana Carolina da Fonseca Mendonça, Alice Sampaio Barreto da Rocha, Fernando Couto Motta, Lídio Gonçãlves Lima Neto, Ricardo Khouri et al. · 2021 · Viruses
58. Superspreading in the emergence of COVID-19 variants
    Alberto Gómez‐Carballa, Jacobo Pardo‐Seco, Xabier Bello, Federico Martinón‐Torres, Antonio Salas · 2021 · Trends in Genetics
59. Evolution of the SARS-CoV-2 genome and emergence of variants of concern
    Iman Safari, Elahe Elahi · 2021 · Archives of Virology
60. The B.1.427/1.429 (epsilon) SARS-CoV-2 variants are more virulent than ancestral B.1 (614G) in Syrian hamsters
    Timothy D. Carroll, Douglas Fox, Neeltje van Doremalen, Erin E. Ball, Mary Kate Morris, Alicia Sotomayor-González, Venice Servellita, Arjun Rustagi, Claude Kwe Yinda, Linda Fritts et al. · 2022 · PLoS Pathogens
61. COVID-19: From emerging variants to vaccination
    Thilini Hemali Senevirathne, Demi Wekking, Joseph W. R. Swain, Cinzia Solinas, Pushpamali De Silva · 2023 · Cytokine & Growth Factor Reviews
62. SARS-CoV-2 Delta variant induces enhanced pathology and inflammatory responses in K18-hACE2 mice
    Katherine S. Lee, Ting Y. Wong, Brynnan P. Russ, Alexander M. Horspool, Olivia A. Miller, Nathaniel A. Rader, Jerome P. Givi, Michael T. Winters, Zeriel Y. Wong, Holly A. Cyphert et al. · 2022 · PLoS ONE
63. COVID-19 spread, detection, and dynamics in Bogota, Colombia
    Laajaj, Rachid, De Los Rios, Camilo, Sarmiento-Barbieri, Ignacio, Aristizabal, Danilo, Behrentz, Eduardo, Bernal, Raquel, Buitrago, Giancarlo, Cucunubá, Zulma, de la Hoz, Fernando, Gaviria, Alejandro et al. · 2021 · Nature Communications
64. Circulating SARS-CoV-2 variants in Italy, October 2020–March 2021
    Alessia Lai, Annalisa Bergna, Stefano Menzo, Gianguglielmo Zehender, Sara Caucci, Valeria Ghisetti, Francesca Maria Rizzo, Fabrizio Maggi, Francesco Cerutti, Giorgio Giurato et al. · 2021 · Virology Journal
65. Discovery of adapalene and dihydrotachysterol as antiviral agents for the Omicron variant of SARS-CoV-2 through computational drug repurposing
    Özkan Fidan, Somdutt Mujwar, Mateusz Kciuk · 2022 · Molecular Diversity
66. The past, current and future epidemiological dynamic of SARS-CoV-2
    François Balloux, Cedric C.S. Tan, Leo Swadling, Damien Richard, Charlotte Jenner, Mala K. Maini, Lucy van Dorp · 2022 · Oxford Open Immunology
67. Characterization of a Novel ACE2-Based Therapeutic with Enhanced Rather than Reduced Activity against SARS-CoV-2 Variants
    Mathieu Ferrari, Leila Mekkaoui, F. Tudor Ilca, Zulaikha Akbar, Reyisa Bughda, Katarina Lamb, Katarzyna Ward, Farhaan Parekh, Rajeev Karattil, Christopher G. Allen et al. · 2021 · Journal of Virology
68. Multivariate mining of an alpaca immune repertoire identifies potent cross-neutralizing SARS-CoV-2 nanobodies
    Hanke, Leo, Sheward, Daniel J., Pankow, Alec, Vidakovics, Laura Perez, Karl, Vivien, Kim, Changil, Urgard, Egon, Smith, Natalie L., Astorga-Wells, Juan, Ekström, Simon et al. · 2022 · Science Advances
69. The in vitro and in vivo efficacy of CT-P59 against Gamma, Delta and its associated variants of SARS-CoV-2
    Dong-Kyun Ryu, Bobin Kang, Hanmi Noh, Sun‐Je Woo, Min‐Ho Lee, Patricia M. Nuijten, Jong‐In Kim, Ji-Min Seo, Cheol-Min Kim, Minsoo Kim et al. · 2021 · Biochemical and Biophysical Research Communications
70. Neutralizing activity of BBIBP-CorV vaccine-elicited sera against Beta, Delta and other SARS-CoV-2 variants of concern
    Xiaoqi Yu, Dong Wei, Wenxin Xu, Chuanmiao Liu, Wentian Guo, Xinxin Li, Wei Tan, Leshan Liu, Xinxin Zhang, Jieming Qu et al. · 2022 · Nature Communications
71. Tracking SARS-COV-2 variants using Nanopore sequencing in Ukraine in 2021
    Anna Yakovleva, Ganna Kovalenko, Matthew Redlinger, Mariia G. Liulchuk, Eric Bortz, В. І. Задорожна, Alla M. Scherbinska, Joel O. Wertheim, Ian Goodfellow, Luke W. Meredith et al. · 2022 · Scientific Reports
72. SARS-CoV-2 variants: biology, pathogenicity, immunity and control
    Ryuta Uraki, Bette Korber, Michael Diamond, Yoshihiro Kawaoka · 2025 · Nature Reviews Microbiology
73. Delayed reaction towards emerging COVID-19 variants of concern: Does history repeat itself?
    Xiaoqian Sun, Sebastian Wandelt, Anming Zhang · 2021 · Transportation Research Part A Policy and Practice
74. Live attenuated virus vaccine protects against SARS-CoV-2 variants of concern B.1.1.7 (Alpha) and B.1.351 (Beta)
    Jakob Trimpert, Julia Maria Adler, Kathrin Eschke, Azza Abdelgawad, Theresa C. Firsching, Nadine Ebert, Tran Thi Nhu Thao, Achim Dieter Gruber, Volker Thiel, Nikolaus Osterrieder et al. · 2021 · Science Advances
75. Genomic monitoring unveil the early detection of the SARS‐CoV‐2 B.1.351 (beta) variant (20H/501Y.V2) in Brazil
    Svetoslav Nanev Slavov, José Salvatore Leister Patané, Rafael dos Santos Bezerra, Marta Giovanetti, Vagner Fonseca, Antonio Jorge Martins, Vincent Louis Viala, Evandra Strazza Rodrigues, Elaine Vieira Santos, Claudia R. S. Barros et al. · 2021 · Journal of Medical Virology
76. The rapid adaptation of SARS-CoV-2–rise of the variants: transmission and resistance
    Sandrine Mabekou Soh, Yeongjun Kim, Chanwoo Kim, Ui Soon Jang, Hye-Ra Lee · 2021 · The Journal of Microbiology
77. Genomic sequencing of SARS-CoV-2 in Rwanda reveals the importance of incoming travelers on lineage diversity
    Yvan Butera, Enatha Mukantwari, Maria Artesi, Jeanne d’Arc Umuringa, Áine O’Toole, Verity Hill, Stefan Rooke, Samuel Leandro Hong, Simon Dellicour, Onesphore Majyambere et al. · 2021 · Nature Communications
78. SARS-CoV-2 Virus−Host Interaction: Currently Available Structures and Implications of Variant Emergence on Infectivity and Immune Response
    Luís Queirós-Reis, Priscilla Gomes da Silva, José Gonçalves, Andrea Brancale, Marcella Bassetto, João R. Mesquita · 2021 · International Journal of Molecular Sciences
79. Parents’ attitudes, knowledge and practice towards vaccinating their children against COVID-19: a cross-sectional study
    Walid A. Al-Qerem, Abdel Qader Al Bawab, Alaa M. Hammad, Tasneem Jaber, Sawsan I. Khdair, Haneen Kalloush, Jonathan Ling, Rami Mosleh · 2022 · Human Vaccines & Immunotherapeutics
80. Impact of mutations in SARS-COV-2 spike on viral infectivity and antigenicity
    Wenyang Zhou, Chang Xu, Pingping Wang, Anastasia A. Anashkina, Qinghua Jiang · 2021 · Briefings in Bioinformatics
81. Cross-Neutralization of Emerging SARS-CoV-2 Variants of Concern by Antibodies Targeting Distinct Epitopes on Spike
    Siriruk Changrob, Yanbin Fu, Jenna J. Guthmiller, Peter Halfmann, Lei Li, Christopher T. Stamper, Haley L. Dugan, Molly Accola, William Rehrauer, Nai-Ying Zheng et al. · 2021 · mBio
82. Tracking the circulating SARS-CoV-2 variant of concern in South Africa using wastewater-based epidemiology
    Rabia Johnson, Jyoti Rajan Sharma, Pritika Ramharack, Noluxabiso Mangwana, Craig John Kinnear, Amsha Viraragavan, Brigitte Glanzmann, Johan Louw, Nada Abdelatif, Tarylee Reddy et al. · 2022 · Scientific Reports
83. Post-acute Sequelae in COVID-19 Survivors: an Overview
    Adekunle O. Sanyaolu, Aleksandra Marinkovic, Stephanie Prakash, Anne Zhao, Vyshnavy Balendra, Nafees Haider, Isha Jain, Teodora Simic, Chuku Okorie · 2022 · SN Comprehensive Clinical Medicine
84. Key mutations in the spike protein of SARS‐CoV‐2 affecting neutralization resistance and viral internalization
    Qiong Wang, Sheng‐Bao Ye, Zhijian Zhou, A‐Ling Song, Xi Zhu, Jia‐Mei Peng, Rui‐Min Liang, Chen‐Hui Yang, Xiaowei Yu, Xun Huang et al. · 2022 · Journal of Medical Virology
85. Setting the Terms for Zoonotic Diseases: Effective Communication for Research, Conservation, and Public Policy
    Julie Teresa Shapiro, Luis Víquez‐R, Stefania Leopardi, Amanda Vicente‐Santos, Ian Hewitt Mendenhall, Winifred F. Frick, Rebekah C. Kading, Rodrigo A. Medellín, Paul A. Racey, Tigga Kingston · 2021 · Viruses
86. SARS-CoV-2 Lambda and Gamma variants competition in Peru, a country with high seroprevalence
    Natalia Vargas‐Herrera, Roger Vladimir Araujo-Castillo, Orson Mestanza, Marco Galarza, Nancy Rojas, Lely Solari · 2021 · The Lancet Regional Health - Americas
87. Characterisation of Omicron Variant during COVID-19 Pandemic and the Impact of Vaccination, Transmission Rate, Mortality, and Reinfection in South Africa, Germany, and Brazil
    Carolina Ribeiro Xavier, Rafael Sachetto Oliveira, Vinícius da Fonseca Vieira, Marcelo Lobosco, Rodrigo Weber dos Santos · 2022 · BioTech
88. CRISPR techniques and potential for the detection and discrimination of SARS-CoV-2 variants of concern
    Huyan Xiao, Jianyu Hu, Camille Huang, Wei Feng, Yanming Liu, Teresa Kumblathan, Jeffrey Tao, Jingyang Xu, X. Chris Le, Hongquan Zhang · 2023 · TrAC Trends in Analytical Chemistry
89. Skin Examination Behavior
    Nadine Angele Kasparian, Richard Bränström, Yu‐Mei Chang, Paul Affleck, Lisa G. Aspinwall, Aad Tibben, Esther Azizi, Orna Baron‐Epel, Linda Battistuzzi, William Bruno et al. · 2012 · Archives of Dermatology
90. Performance of vaccination with CoronaVac in a cohort of healthcare workers (HCW) - preliminary report
    Elizabeth de Faria, Ana Rúbia Guedes, Maura Salaroli de Oliveira, Moacyr Vergara de Godoy Moreira, Fernando Liebhart Maia, Antonio dos Santos Barboza, Mariana Deckers Leme, Leila Suemi Harima Letaif, Anna Miethke-Morais, Eloísa Bonfá et al. · 2021 · medRxiv
91. Coincident rapid expansion of two SARS-CoV-2 lineages with enhanced infectivity in Nigeria
    Ozer, Egon A., Simons, Lacy M., Adewumi, Olubusuyi M., Fowotade, Adeola A., Omoruyi, Ewean C., Adeniji, Johnson A., Dean, Taylor J., Zayas, Janet, Bhimalli, Pavan P., Ash, Michelle K. et al. · 2021
92. Epidemiology, not geopolitics, should guide COVID-19 vaccine donations
    Bollyky, Thomas J, Murray, Christopher J L, Reiner, Robert C · 2021 · The Lancet
93. The variants of SARS‐CoV‐2 and the challenges of vaccines
    Xiucui Han, Qing Ye · 2021 · Journal of Medical Virology
94. Regional and temporal coordinated mutation patterns in SARS-CoV-2 spike protein revealed by a clustering and network analysis
    Surendra S. Negi, Catherine H. Schein, Werner A. Braun · 2022 · Scientific Reports
95. Metagenomic pathogen sequencing in resource-scarce settings: Lessons learned and the road ahead
    Christina Yek, Andrea R. Pacheco, Manu Vanaerschot, Jennifer A. Bohl, Elizabeth Fahsbender, Andrés Aranda-Díaz, Sreyngim Lay, Sophana Chea, Meng Heng Oum, Chanthap Lon et al. · 2022 · Frontiers in Epidemiology
96. Divergent trajectories of antiviral memory after SARS-CoV-2 infection
    Adriana Tomić, Donal Skelly, Ane Ogbe, Daniel O’Connor, Matthew J. Pace, Emily Adland, Frances Alexander, Mohammad Ali, Kirk Allott, M. Azim Ansari et al. · 2022 · Nature Communications
97. Risk assessment for long- and short-range airborne transmission of SARS-CoV-2, indoors and outdoors
    Florian Poydenot, Ismael Abdourahamane, Elsa Caplain, Samuel Der, Jacques Haiech, Antoine Jallon, Inés Khoutami, Amir Loucif, Emil Marinov, Bruno Andreotti · 2022 · PNAS Nexus
98. City-wide wastewater genomic surveillance through the successive emergence of SARS-CoV-2 Alpha and Delta variants
    Franziska S. Brunner, Mathew Robert Brown, Irene Bassano, Hubert Denise, Mohammad S. Khalifa, Matthew J. Wade, Ronny van Aerle, Jessica L. Kevill, Davey L. Jones, Kata Farkas et al. · 2022 · Water Research
99. Covid-19: Brazil’s spiralling crisis is increasingly affecting young people
    Luke Taylor · 2021 · BMJ
100. SARS-CoV-2 B.1.617 emergence and sensitivity to vaccine-elicited antibodies
     Petra Mlčochová, Steven A. Kemp, Mahesh Shanker Dhar, Guido Papa, Bo Meng, Swapnil Mishra, Charles Whittaker, Thomas A. Mellan, Isabella Ferreira, Rawlings P. Datir et al. · 2021 · Greater South Information System